[Correspondence] Treatment of tenosynovial giant-cell tumour types

Leggi l'articolo originale


We read with great interest the international, retrospective, cohort study by Monique Mastboom and colleagues1 reporting surgical outcomes of diffuse-type tenosynovial giant-cell tumours, and comments by William Tap on the importance of multidisciplinary care for this disease.2 Mastboom and colleagues’ study analysed surgical outcomes, with particular emphasis on postoperative recurrence and complications. Tap mentioned the usefulness of colony-stimulating factor 1 receptor inhibitors, a molecular targeted therapy, for patients with tenosynovial giant-cell tumours, and the importance of the indications by which medical oncologists select them.

Lascia un commento